Drug reference and clinical information provider Lexi-Comp has reached an agreement to be sold for an unspecified amount to information services firm Wolters Kluwer.
Hudson, Ohio-based Lexi-Comp sells mobile, online and printed content for doctors, pharmacists, hospitals and universities. The 150-employee company was founded in 1978. It may be best known for publishing drug reference handbooks for doctors that provide detailed information on drug uses and interactions.
Netherlands-based Wolters Kluwer said the deal was part of its strategy to increase its point-of-care offerings, according to a statement from the company.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“Following completion of the acquisition, our combined businesses will be well positioned to provide a robust portfolio of clinical decision support solutions for professional customers across the healthcare continuum,” said Arvind Subramanian, president of Wolters Kluwer Health Clinical Solutions.
Lexi-Comp provides drug information and medical reference content to more than 1,500 hospitals across the globe, according to the statement.
A Lexi-Comp spokeswoman didn’t immediately return a call.
